Opaleye Management Inc. - Jan 28, 2022 Form 4 Insider Report for Tracon Pharmaceuticals, Inc. (TCON)

Role
10%+ Owner
Signature
Opaleye Management Inc., By: /s/ James Silverman, President
Stock symbol
TCON
Transactions as of
Jan 28, 2022
Transactions value $
$1,100
Form type
4
Date filed
1/31/2022, 03:05 PM
Previous filing
Jan 24, 2022
Next filing
Mar 17, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TCON Common Stock, par value $0.001 per share Purchase $1.1K +500 +0.02% $2.20* 2.82M Jan 28, 2022 By Opaleye, L.P. F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding TCON Prefunded Warrants 1.89M Jan 28, 2022 Common Stock 1.89M $0.01 By Opaleye,L.P. F3
holding TCON Prefunded Warrants 1.36M Jan 28, 2022 Common Stock 1.36M $0.01 By Opaleye,L.P. F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents securities owned directly by Opaleye, L.P. (the "Fund"). As the investment manager of the Fund, Opaleye Management Inc. may be deemed to beneficially own the securities owned directly by the Fund.
F2 The common stock was purchased by the reporting person in open market transactions on the transaction date, with a purchase price of $2.20
F3 The warrants may not be exercised to the extent that such exercise would cause the reporting person and its affiliates to beneficially own more than 9.99% of the issuers then outstanding shares.